CV Sciences, Inc. (CVSI)

Market Cap	1.76M -69.2%
Revenue (ttm)	12.74M -14.9%
Net Income	-2.01M
EPS	-0.01
Shares Out	225.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,591,353
Open	0.0095
Previous Close	0.0090
Day's Range	0.0072 - 0.0095
52-Week Range	0.0071 - 0.1000
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About CV Sciences

CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed it...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 44
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVSI

Financial Performance

In 2025, CV Sciences's revenue was $13.79 million, a decrease of -12.20% compared to the previous year's $15.71 million. Losses were -$958,000, -59.98% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 6, 2026

Data Sources Report a data error